We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FS... Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States. Show more
NOTE: The new presentation time for Auriniaโs presentation at the 2024 Bloom Burton & Co. Healthcare Investor Conferences is 4:00 to 4:30 PM Eastern Time. This event is presentation only...
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release financial and operational results for the first quarter of 2024 on Thursday, May 2, 2024...
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will attend the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place at the Metro...
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that Canadian securities regulators have granted exemptive relief for the Companyโs share repurchase program...
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that management will be participating in the following upcoming investor conferences during the month of...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.03 | -0.597609561753 | 5.02 | 5.226 | 4.71 | 1430812 | 4.96135387 | CS |
4 | -0.04 | -0.795228628231 | 5.03 | 5.41 | 4.71 | 1346756 | 5.04944418 | CS |
12 | -3.1 | -38.3189122373 | 8.09 | 8.5 | 4.71 | 2154806 | 5.98902912 | CS |
26 | -2.69 | -35.0260416667 | 7.68 | 10.05 | 4.71 | 2100371 | 7.29340621 | CS |
52 | -5.95 | -54.3875685558 | 10.94 | 12.43 | 4.71 | 2191598 | 8.68782927 | CS |
156 | -7.21 | -59.0983606557 | 12.2 | 33.9715 | 4.07 | 2946555 | 12.50632634 | CS |
260 | -1.28 | -20.4146730463 | 6.27 | 33.9715 | 3.52 | 2509813 | 13.01397261 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions